Keyphrases
Conventional Therapy
100%
Antibody-mediated Rejection
100%
Novel Therapies
100%
Renal Allograft Outcomes
100%
Serum Creatinine
44%
Odds Ratio
33%
Donor-specific Antibodies
33%
Bortezomib
22%
Delayed Diagnosis
22%
Immunosuppression
22%
Older Patients
22%
Histologic
11%
Consecutive Patients
11%
Rituximab
11%
Lack of Response
11%
Follow-up Biopsy
11%
Kidney Transplant
11%
Single Center
11%
Response to Therapy
11%
Non-adherence
11%
Intravenous Immunoglobulin (IVIg)
11%
Banff
11%
Histological Response
11%
Allograft Vasculopathy
11%
Vasculopathy
11%
Plasmapheresis
11%
Potential Adverse Effects
11%
End of Therapy
11%
Histologic Improvement
11%
Medicine and Dentistry
Antibody Mediated Rejection
100%
Kidney Allograft
100%
Creatinine
44%
Odds Ratio
33%
Antibodies
33%
Biopsy
22%
Immunosuppressive Treatment
22%
Bortezomib
22%
Kidney Graft
11%
Adverse Event
11%
Vascular Disease
11%
Low Drug Dose
11%
Rituximab
11%
Plasmapheresis
11%
Allograft Vasculopathy
11%
Immunology and Microbiology
Allotransplantation
100%
Antibody Mediated Rejection
100%
Creatinine Blood Level
44%
Monospecific Antibody
33%
Immunosuppression
22%
Transplant Procedure
11%
Low Drug Dose
11%
Rituximab
11%
Allograft Vasculopathy
11%
Plasmapheresis
11%